|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.19 USD | -2.63% |
|
-4.24% | +38.03% |
| Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
| Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell 3000E Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| +38.03% | 285M | |
| +4.86% | 69.91B | |
| +10.97% | 9.03B | |
| -17.03% | 4.75B | |
| +37.51% | 4.31B | |
| +3.92% | 3.88B | |
| +15.70% | 2.37B | |
| -24.13% | 2.26B | |
| -29.70% | 2.2B | |
| +9.09% | 1.98B |
CORMEDIX INC. 
